BACKGROUND: CRM- based pneumococcal conjugate vaccines generally have little impact on the overall prevalence of pneumococcal carriage because of serotype replacement. In contrast, protein vaccines could substantially reduce the overall prevalence of pneumococcal carriage with potential microbiological and clinical consequences. Therefore, trials of pneumococcal protein vaccines need to evaluate their impact on carriage of other potentially pathogenic bacteria in addition to the pneumococcus. METHODS: As a prelude to a trial of an investigational pneumococcal vaccine containing pneumococcal polysaccharide conjugates and pneumococcal proteins, the prevalence of carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella species a...
BACKGROUND: Infection with Streptococcus pneumoniae is a major cause of childhood morbidity and mort...
BACKGROUND: In West Africa, the carriage of Group B Streptococcus (GBS), among infants is poorly cha...
Background: In developing countries, introduction of pneumococcal conjugate vaccine has not eliminat...
Staphylococcus aureus and Streptococcus pneumoniae commonly colonize the upper respiratory tract and...
BACKGROUND: To prepare for national introduction of a pneumococcal conjugate vaccine of restricted v...
AbstractStaphylococcus aureus and Streptococcus pneumoniae commonly colonize the upper respiratory t...
BACKGROUND: To prepare for the introduction of a pneumococcal conjugate vaccine of restricted valenc...
INTRODUCTION: The currently used Streptococcus pneumoniae vaccines have had a significant impact on ...
Background Conserved pneumococcal proteins are potential candidates for inclusion in vaccines again...
INTRODUCTION: In 2011, two years after the introduction of 7-valent Pneumococcal conjugate vaccine (...
BACKGROUND: Nasopharyngeal carriage of Streptococcus pneumoniae is extremely prevalent in The Gambia...
OBJECTIVE: Pneumococcal conjugate vaccines reduce the prevalence of vaccine serotypes carried in the...
BACKGROUND: Although Haemophilus influenzae type b (Hib), Staphylococcus aureus and Moraxella catarr...
BACKGROUND: This study evaluated the impact of age and pneumococcal vaccination on the density of pn...
OBJECTIVE: To assess the effect of vaccines against pneumonia in Gambian children. METHODS: Data fro...
BACKGROUND: Infection with Streptococcus pneumoniae is a major cause of childhood morbidity and mort...
BACKGROUND: In West Africa, the carriage of Group B Streptococcus (GBS), among infants is poorly cha...
Background: In developing countries, introduction of pneumococcal conjugate vaccine has not eliminat...
Staphylococcus aureus and Streptococcus pneumoniae commonly colonize the upper respiratory tract and...
BACKGROUND: To prepare for national introduction of a pneumococcal conjugate vaccine of restricted v...
AbstractStaphylococcus aureus and Streptococcus pneumoniae commonly colonize the upper respiratory t...
BACKGROUND: To prepare for the introduction of a pneumococcal conjugate vaccine of restricted valenc...
INTRODUCTION: The currently used Streptococcus pneumoniae vaccines have had a significant impact on ...
Background Conserved pneumococcal proteins are potential candidates for inclusion in vaccines again...
INTRODUCTION: In 2011, two years after the introduction of 7-valent Pneumococcal conjugate vaccine (...
BACKGROUND: Nasopharyngeal carriage of Streptococcus pneumoniae is extremely prevalent in The Gambia...
OBJECTIVE: Pneumococcal conjugate vaccines reduce the prevalence of vaccine serotypes carried in the...
BACKGROUND: Although Haemophilus influenzae type b (Hib), Staphylococcus aureus and Moraxella catarr...
BACKGROUND: This study evaluated the impact of age and pneumococcal vaccination on the density of pn...
OBJECTIVE: To assess the effect of vaccines against pneumonia in Gambian children. METHODS: Data fro...
BACKGROUND: Infection with Streptococcus pneumoniae is a major cause of childhood morbidity and mort...
BACKGROUND: In West Africa, the carriage of Group B Streptococcus (GBS), among infants is poorly cha...
Background: In developing countries, introduction of pneumococcal conjugate vaccine has not eliminat...